A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity

Authors

Mark E. Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Mauricio R. Delgado, University of Texas Southwestern Medical Center, Dallas, TX
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Francoise Calvi-Gries, Ipsen, Boulogne-Billancourt, France
Jumaah Goldberg, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

9-18-2022

Publication Title

Developmental Medicine and Child Neurology

Abstract

76th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine, AACPDM 2022, September 21 - 24, 2022

Volume

64

Issue

Supplement 4

Publisher

Wiley

Comments

Abstract SP60

Rights

© 2022 The Authors. Developmental Medicine & Child Neurology © 2022 Mac Keith Press

Recommended Citation

Gormley, Mark E.; Dabrowski, Edward; Delgado, Mauricio R.; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Calvi-Gries, Francoise; and Goldberg, Jumaah, "A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity" (2022). School of Medicine Faculty Publications. 4149.
https://digitalscholar.lsuhsc.edu/som_facpubs/4149
10.1111/dmcn.15356